Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

The Relation Between Depression and Visual Functioning. The AREDS Study

Go back to Resources

The Relation Between Depression and Visual Functioning. The AREDS Study

Authors:

Secondary:

Location:

URL:

Go back to Resources

The Effect of AREDS Supplementation on Visual Acuity Loss in Eyes with Advanced AMD

Go back to Resources

The Effect of AREDS Supplementation on Visual Acuity Loss in Eyes with Advanced AMD

Authors:

Secondary:

Location:

URL:

Go back to Resources

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 17

Go back to Resources

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 17

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Serum Nutrient Levels as Risk Factors for Neovascular AMD

Go back to Resources

Serum Nutrient Levels as Risk Factors for Neovascular AMD

Authors:

Secondary:

Location:

URL:

Go back to Resources

Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS

Go back to Resources

Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS

Authors:

Location:

URL:

Go back to Resources

Phase I Study of Ciliary Neurotrophic Factor (CNF) Delivered By Intravitreal Implant of Encapsulated Cell Technology (ECT) Device in Patients with Retinitis Pigmentosa

Go back to Resources

Phase I Study of Ciliary Neurotrophic Factor (CNF) Delivered By Intravitreal Implant of Encapsulated Cell Technology (ECT) Device in Patients with Retinitis Pigmentosa

Authors:

Secondary:

Location:

Go back to Resources

Interim results of the International Multi-Center Trial of Islet Transplantation Using the Edmonton Protocol in Patients with Type 1 Diabetes

Go back to Resources

Interim results of the International Multi-Center Trial of Islet Transplantation Using the Edmonton Protocol in Patients with Type 1 Diabetes

Authors:

Location:

Go back to Resources

Induction of human T-Cell-Mediated immune responses after primary and secondary smallpox vaccination

Go back to Resources

Induction of human T-Cell-Mediated immune responses after primary and secondary smallpox vaccination

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial

Go back to Resources

Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial

Authors:

Secondary:

Pagination:

Go back to Resources

Estimated reates of progression to advanced AMD and vision loss by baseline maculopathy status: Results from the Age-Related Eye Disease Study

Go back to Resources

Estimated reates of progression to advanced AMD and vision loss by baseline maculopathy status: Results from the Age-Related Eye Disease Study

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Current page 154
  • Page 155
  • Page 156
  • Page 157
  • Page 158
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification